MUMBAI (Reuters) - Indian generic drugmaker Aurobindo Pharma Ltd said on Wednesday its U.S. unit won a bankruptcy auction to buy nutritional supplements maker Natrol Inc for $132.5 million.
Aurobindo said the deal with Chatsworth, California-based Natrol, which sells vitamins and supplements as well as diet and weight management products, will help the company expand its over-the-counter products business in the United States.
The deal is pending final approval by the United States Bankruptcy Court for the District of Delaware, Aurobindo said in a statement.
Barclays provided legal advice to Aurobindo on the deal, while Sullivan & Cromwell LLP was the company's legal counsel.
Aurobindo's shares were up 4 percent at 1,066 rupees at 10:17 a.m. on Wednesday, while the Nifty was up 0.4 percent.
(Reporting by Zeba Siddiqui in Mumbai; Editing by Anupama Dwivedi)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app